Pre-clinical safety studies of intranasal virus-like particles based vaccine for prevention of COVID-19
- Authors: Chernoryzh Y.Y.1, Kondratieva V.M.1, Malkova А.P.2, Savochkina T.E.1, Eliseeva O.V.1, Latyshev O.E.1, Yakunin D.Y.1, Zaykova O.N.1, Sludnyakova E.S.1, Grebennikova T.V.1
-
Affiliations:
- National Research Center for Epidemiology and Microbiology named after Honorary Academician N.F. Gamaleya of the Ministry of Health of the Russian Federation
- Institute for Biomedical Research and Technology (IMBIIT)
- Section: ORIGINAL RESEARCH
- Submitted: 04.12.2024
- Accepted: 15.01.2025
- Published: